CDKN2A and urinary bladder cancer: P16 gene amplification accompanied p16INK4a overexpression group predicts a bad prognosis (P = .023), and loss of P16 accompanied loss of p16INK4a expression group has the tendency (P = .067) to predict a bad prognosis of urinary bladder cancer.